HealthWell Foundation Opens Pulmonary Fibrosis Patient Fund

HealthWell Foundation Opens Pulmonary Fibrosis Patient Fund

The independent, non-profit HealthWell Foundation is launching a new fund dedicated to supporting patients who suffer from pulmonary fibrosis. The main mission of the foundation is to offer financial help to underinsured people in the United States in order to improve their access to life-changing medical treatments.

Research and Markets Presents 2015 Pulmonary Fibrosis Pipeline Review

A recent report on Research and Markets covered this year’s featured companies’ Pipeline Therapeutics for the annual Pulmonary Fibrosis Review. The report details descriptions of 56 companies currently developing treatment strategies for therapeutics for Pulmonary Fibrosis. The team conducted comparative analysis of the companies’ compounds under clinical investigation at various stages, and…

Galapagos Reports Positive Results For Phase 1 Trial of PF Therapy

Galapagos NV recently announced that GLPG1690, its molecule to address pulmonary diseases such as pulmonary fibrosis, has demonstrated target engagement and a very good safety profile, with Phase 1 results showing favorable drug properties. Galapagos is now advancing GLPG1690 with partner Janssen Pharmaceutica NV. Pulmonary fibrosis…

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums